ADAM Trial Pilot
With the change in season marks the beginning of the end of the pilot phase of the ADAM trial. Recruitment has offcially begun across the five study sites, with all sites successfully recruiting their first participant. Thank you to all the clinical teams for their referrals and ongoing support.
We are pleased to report we currently have thirty-one participants recruited across all five sites and have begun to complete the first two-month follow-ups.
Our Birmingham site is steaming ahead with eleven participants successfully recruited. Researchers from all sites have been working hard with clinical teams to identify suitable participants. We will continue to work to reach our target of eleven participants per site per month.
The recruitment push will continue as we look to complete the pilot phase this autumn. Thank you for all the referrals so far and to all participants who have signed up!
A warm welcome to Maria-Leoni Koutsou!
She is the new research assistant based in Birmingham.
Delivering relapse prevention medication training to primary care
Following the identification of training needs in primary care services by Central North West London (CNWL) alcohol services, the research team organised a training session, ‘Alcohol Dependence and Relapse Prevention Medication in Primary Care’ to provide an opportunity to build links between primary and secondary care services.
This training and networking event had over thirty GPs, practice nurses, pharmacists, consultant psychiatrists and recovery workers from across the eight boroughs in CNWL come together. The training session was delivered by Professor Anne Lingford-Hughes from Imperial College London. She shared her breadth of clinical experience and academic knowledge with the room. The session raised awareness of alcohol related harm and developed skills and knowledge to manage alcohol related problems in primary care.
The ADAM team are committed to building links between primary and secondary care to improve patient care and treatment pathways. The feedback from the event has been overwhelming positive. Special thanks to Ealing CCG and Alcohol Research UK for their support in organizing this event.
Trial Launch Date 19 July 2016
We are thrilled to announce the launch of the ADAM Study, recruitment has begun across the five study sites, and we look forward to updating you with progress in the Autumn newsletter. Thanks to everyone involved with getting to this point, we appreciate the support from you all. Thanks also to the clinical teams for their patience while we wait to launch the study.
Congratulations to the ADAM Trial Manager Dr Kim Donoghue on the birth of her baby boy in early June
We’d like to give a warm welcome to Dr Sadie Boniface who is in post to cover Kim’s maternity leave – welcome to the team Sadie!
Building links with CNWL addiction specialist services
To continue the further development of our telephone intervention pharmacists we conducted a training and networking event with the Central and North West London (CNWL) Addiction Specialist Pharmacists. This session helped build links and relationships between our trial pharmacists and addiction specialist pharmacists. This meeting provided a unique learning opportunity for the telephone pharmacists to gain insight and understanding of the range of support given by pharmacists in drug and alcohol service. Many thanks to Fahreen Hasham, Noor Assadi and Soyar Sherkat who shared their time and wisdom with us.
Training and development
Visit the link below for the latest available MOOCs:
Information on Good Clinical Practice Training is available here:
NIHR New Media Competition
The ADAM team entered the NIHR New Media Competition, and created a 2 minute video about the study and Patient and Public Involvement in developing the trial. Unfortunately we were not successful in being shortlisted, but you can read the story of creating the video in the ADAM Study Blog.
You can view the video here: https://youtu.be/XH1_Tc7lMug
Special congratulations to Professor Sir John Strang who received a Knighthood in the Queen’s birthday honors this year for services to medicine, addiction and public health.
Professor Strang is Head of the Addictions Department in the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) and is also Leader of the Addictions Clinical Academic Group of King’s Health Partners Academic Health Science Centre.
Wishing everyone a lovely Summer!
The trial will go live in January 2016!
The ADAM study is a national trial exploring how service users could be supported to take the medication acamprosate by pharmacists. There is good evidence for the effectiveness of acamprosate for preventing relapse to dependent drinking. Despite this, adherence to this medication is low and therefore the positive benefit that could be gained from taking it is not reached in all patients. The unique aspect of this study is that it will involve pharmacists who will be trained to support patients to take acamprosate as prescribed. This study is led by Professor Colin Drummond, Institute of Psychiatry, Psychology & Neuroscience; King’s College London, is funded by The National Institute for Health Research and is listed as a National Portfolio study.
Training and development
· · ·
Register your interest now for the Addictions MOOC
Understanding Drugs and Addiction massive open online course (MOOC) starts on the 7th March 2016. This free course explores how addictions develop, looking at the environmental, genetic and individual risks, best practice in treatment and policy, future directions in addiction science. Over 34,000 people have enrolled in this course over the past two years. Register your interest now here!
Telephone Support Pharmacist’s Training Complete
In November we delivered the two-day training for the telephone support pharmacists on the medication management (MM) intervention and contingency management (CM). MM is a brief discussion that involves receiving information, advice and support about alcohol and acamprosate over the phone. CM is a voucher incentive the participants receive for engaging in the telephone intervention.
Over the two days the pharmacists role-played different scenarios with actors and practiced advanced communication and interpersonal skills. The training also encouraged reflective practice and an empathetic approach to delivering the intervention. The pharmacists have been trained to support the patients in developing strategies to manage their medication, including understanding how acamprosate works, adhering to the dosage, managing side-effects and education about their medication and alcohol dependence.
Although intensive the feedback from the training has been extremely positive. The ADAM team will continue to support and advise the telephone support pharmacists through the project.
The research team has been busy visiting the community pharmacies that are taking part across London and Birmingham this term. All London community pharmacy visits are complete! The visits have been very positive with many pharmacists expressing an interest in alcohol dependency research. Visits for Hull and Southampton will start in the New Year.
|We are pleased to welcome our telephone support pharmacists Ikhlaq Hussain and Radu Juverdeanu to the ADAM team!